These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 10090310
1. Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study. Kimura ET, Kopp P, Zbaeren J, Asmis LM, Ruchti C, Maciel RM, Studer H. Thyroid; 1999 Feb; 9(2):119-25. PubMed ID: 10090310 [Abstract] [Full Text] [Related]
2. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer. Nilsson E, Doraiswamy V, Parrott JA, Skinner MK. Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049 [Abstract] [Full Text] [Related]
3. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid]. Wang T, Jiang CX, Li Y, Liu X. Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458 [Abstract] [Full Text] [Related]
9. Expression and significance of IGF-1 and IGF-1R in thyroid nodules. Liu YJ, Qiang W, Shi J, Lv SQ, Ji MJ, Shi BY. Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662 [Abstract] [Full Text] [Related]
15. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton. Molin DG, Bartram U, Van der Heiden K, Van Iperen L, Speer CP, Hierck BP, Poelmann RE, Gittenberger-de-Groot AC. Dev Dyn; 2003 Jul; 227(3):431-44. PubMed ID: 12815630 [Abstract] [Full Text] [Related]
17. Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesions. Nagy N, Decaestecker C, Dong X, Kaltner H, Schüring MP, Rocmans P, Danguy A, Gabius HJ, Kiss R, Salmon I. Histol Histopathol; 2000 Apr; 15(2):503-13. PubMed ID: 10809372 [Abstract] [Full Text] [Related]
18. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. Bidot P, Morgan M, Zhukov T, Tannenbaum M, Tockman MS. Endocr Pract; 2001 Apr; 7(3):157-61. PubMed ID: 11421561 [Abstract] [Full Text] [Related]
19. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV. Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [Abstract] [Full Text] [Related]